• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
  • 0Shopping Cart
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

NCCS Starburst 250px

What Caught Our Eye: High-Risk Pools, “Trumpcare,” Childhood Cancer Survivors, Medicaid Spending, Trump’s FDA Deregulation

March 3, 2017/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Clinical Trials, Health Care Coverage, Pre-Existing Conditions NCCS News /by actualize
What Caught Our Eye (WCOE), March 3, 2017
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

“States Be Warned: High-Risk Pools Offer Little Help At A High Cost”

Do high-risk pools offer little help at a high cost to states? Lessons from the #ACA's PCIP program give us insight https://t.co/dBz5BZt3vK

— Health Affairs (@Health_Affairs) February 28, 2017

“Recently, House Republican Leadership announced a new ‘State Innovation Grants’ program as part of its plan and draft legislation to replace the Affordable Care Act (ACA). These funds could be used for high-risk pools among other purposes… Putting prior experience aside, the ACA itself offers insight into this type of program and, as our report for the Century Foundation suggests, high-risk pools’ flaws may be more fatal than previously thought.“

Read More »


“Trumpcare Vs. Obamacare”

My @NewYorker Comment on the growing recognition of the good #Obamacare has done and the effect on #Trumpcare https://t.co/qmjzAwi4PF

— Atul Gawande (@Atul_Gawande) March 1, 2017

“The pitchforks are changing hands. In 2009, it was Democratic members of Congress supporting health-care reform who were set upon by outraged constituents. When they passed the Affordable Care Act anyway, it cost their party control of Congress in the 2010 midterm elections… But Obamacare, it turns out, has done a lot of good… Now Republicans in Congress are facing the wrath of constituents who don’t want to lose those gains.”

Read More »


“Trump Proposed 5 Specific Policies to Replace Obamacare. Here’s How They Work.”

https://twitter.com/sarahkliff/status/836784724387348480
“President Donald Trump used his first congressional address to deliver a five-point outline of some policies he supports in an Obamacare repeal-and-replace plan.

Trump only briefly explained each, but what he described are in line with what we know House Speaker Paul Ryan and Health and Human Services Secretary Tom Price support.”

Read More »


“Health Care’s Bipartisan Problem: The Sick Are Expensive and Someone Has to Pay”

Want to cover people with pre-existing conditions? First question: Who pays? https://t.co/zjRj3oje26 via @WSJ

— Anna Mathews (@annawmathews) January 12, 2017

“Congress has begun the work of replacing the Affordable Care Act, and that means lawmakers will soon face the thorny dilemma that confronts every effort to overhaul health insurance: Sick people are expensive to cover, and someone has to pay.”

Read More »


“Faring Better Than Many ACA Insurers, Molina Backs Health Law ‘Tuneup’”

Despite a disappointing fourth quarter of 2016, Molina remains a fan of the Affordable Care Act overall. https://t.co/2Br4V0S8cO

— Kaiser Health News (@KHNews) March 2, 2017

“Some large health insurance companies have suffered losses under the Affordable Care Act, leading to a few high-profile exits from the online marketplaces. Humana is just the latest, announcing in January that it will stop offering health insurance on the ACA health exchanges at year’s end.

But the administrators of a smaller, California-based insurer — Molina Healthcare — managed to turn a modest profit in the early years of the 2010 health law and break even in 2016. How did they do it?”

Read More »


“Voters Want More Money Spent on Medicaid, but Don’t Think Trump Will”

New poll this a.m.: Voters want more federal $ for Medicaid, but almost half don't think Trump will spend https://t.co/QFnJrxq6JK

— Mary Ellen McIntire (@MelMcIntire) February 28, 2017

“A plurality of voters wants the federal government to spend more on Medicaid, a new Morning Consult/POLITICO poll finds.”

Read More »


Cancer Policy

“Would Trump’s FDA Deregulation Create An Age of Miracles? Don’t Bet On It”

My look at the FDA under Trump, with data on 24 drugs that FDA did not approve when other countries did. https://t.co/f3hWjvKuTe

— Matthew Herper (@matthewherper) March 1, 2017

“In his first address to a joint session of Congress, President Donald Trump made a dramatic appeal for lowering the hurdles new medicines face in gaining approval from the Food and Drug Administration. But Trump’s promises–that reduced regulatory standards would result in more cures reaching the market and lower drug prices–may be hard to keep.”

Read More »


Cancer News

“Childhood Cancer Survivors Benefit from Reduced Radiation Treatment”

Another sign of steady improvements in cancer treatment: Second cancer rate is way down. By @LaurieMcGinley2 https://t.co/l9vqAH9UU0

— Laura Helmuth (@laurahelmuth) February 28, 2017

“The rate of second malignancies in survivors of childhood cancer is declining — an improvement linked to reduced radiation treatment of the first disease, according to a new study.”

Read More »


“Colon and Rectal Cancers Rising in Young People”

Colorectal is a disease of aging, but it's increasing among young adults.https://t.co/KRmTOiRiUp

— Roni Rabin (@RoniNYTimes) February 28, 2017

“Cancers of the colon and rectum have been declining in older adults in recent decades and have always been considered rare in young people. But scientists are reporting a sharp rise in colorectal cancers in adults as young as their 20s and 30s, an ominous trend.”

Read More »


More From “What Caught Our Eye” »

Follow us on Twitter: @canceradvocacy


Tags: affordable care act, cancer care, Cancer Survivorship, childhood cancer, clinical trials, FDA, high-risk pools, Medicaid, pre-existing conditions, What Caught Our Eye
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2017/01/NCCS-Starburst-250px.png 250 250 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2017-03-03 16:40:562017-03-03 16:40:56What Caught Our Eye: High-Risk Pools, “Trumpcare,” Childhood Cancer Survivors, Medicaid Spending, Trump’s FDA Deregulation
You might also like
NCCS Starburst Thumbnail Article Reports Tendency of Investigators to Underreport Side Effects of Chemo in Clinical Trials
NCCS Blog CPM Logo 17 Patient Groups Urge Appeals Court to Uphold Health Care Law
Fotolia 23428619 S e1461260836640 NCCS Joins Letter to Congressional Leaders Regarding the Affordable Care Act
20years Guest Post: Developing Clinical Solutions to Improve Survivorship Care: The Value of Partnership
NCCS Starburst 250px What Caught Our Eye: ACA Debate, Thyroid Cancer Late Effects, Long-Term Follow-Up Care, Cervical Cancer Mortality, and Anxiety in Partners of Breast Cancer Survivors
NCCS Starburst 250px What Caught Our Eye: ACA Repeal Debate, the Trump FDA Transition, and Cancer-Related Fatigue
NCCS Starburst 250px Health Care Roundup: Association Health Plans and ACA Repeal; Benefits of Exercise for Childhood Survivors; NIH Grant System; and More
20years NCCS CEO Shelley Fuld Nasso Introduces the Sixth Principle of the Imperatives for Quality Cancer Care

Latest News

HHS Humphrey bldg 1200

NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care

December 22, 2020
The National Coalition for Cancer Survivorship (NCCS) joined other member organizations…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-22 20:27:262021-01-04 21:38:15NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care
NCCS Letter to HHS

NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients

December 9, 2020
The National Coalition for Cancer Survivorship (NCCS) recently submitted comments…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200-1030x515-1.jpg 515 1030 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-09 17:30:502020-12-10 08:22:55NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients
HHS Humphrey bldg 1200

NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

December 3, 2020
The National Coalition for Cancer Survivorship (NCCS) opposes the Most Favored Nation…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-03 21:26:462020-12-03 21:28:06NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

ACA Update | March 2, 2017: GOP Tax Credits, Medicaid Proposals, and a ‘Secret’... ProtectOurCare 1024px ProtectOurCare 1024px NCCS Statement on the American Health Care Act
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute